DexCom, Inc.
Business Model Analysis
How DexCom Makes Money
Annual Revenue: $4.7B
- How does DexCom make money?
- DexCom makes money from Continuous Glucose Sensors, Transmitters & Hardware Kits, Stelo Over-the-Counter Biosensors and Software & Automated Pump Partnerships.
DexCom generates revenue primarily through Medical Devices, with roughly $4.7B in annual revenue.
Core Growth Engine: Extend CGM from intensive insulin users to the much larger type 2 population, sell Stelo over the counter to adults not on insulin, lengthen sensor wear time, and add manufacturing capacity outside the United States....
Revenue Model & Pricing
Dexcom earns most of its revenue from disposable sensors that users replace every 10 to 15 days, which makes sales recurring. In the United States the sensors are sold mainly through pharmacies and distributors and paid for by insurers, Medicare and Medicaid; Stelo is sold directly to consumers without a prescription.
Core Revenue Streams
Continuous Glucose Sensors (Consumables)
75.0%Recurring monthly disposable sensor refills reimbursed through commercial insurance, Medicare, Medicaid, and direct purchases.
Transmitters & Hardware Kits
15.0%Reusable long-life electronic transmitters and starter kits connecting sensors to receivers and mobile applications.
Stelo Over-the-Counter Biosensors
5.0%Direct-to-consumer biosensor products tailored specifically for type 2 diabetes adults not on insulin.
Software & Automated Pump Partnerships
5.0%Licensing and data integration fees generated from automated insulin pump partners such as Tandem Control-IQ and Insulet Omnipod 5.
Growth Strategy
Extend CGM from intensive insulin users to the much larger type 2 population, sell Stelo over the counter to adults not on insulin, lengthen sensor wear time, and add manufacturing capacity outside the United States.
How DexCom Makes Money: FAQ
What are the primary revenue streams for Dexcom?
Dexcom generates consolidated revenue through multi-faceted operational channels, including core product and service fees, interest margin spreads, long-term subscription or administrative contracts, and ancillary value-added services, producing $4.66B in annual turnover.
How does Dexcom achieve operating leverage?
Dexcom achieves exceptional operating leverage by deploying proprietary automated digital infrastructure that handles rising transaction volumes without proportionate increases in workforce headcount or administrative overhead.
Who are Dexcom's target customer segments?
Dexcom serves a broad spectrum of commercial and consumer clients, spanning individual retail households, small-to-medium businesses, large multinational corporations, and institutional investment entities requiring mission-critical solutions.
How does Dexcom manage operational and credit risk?
Dexcom enforces strict risk management governance, automated real-time compliance surveillance, conservative capital adequacy reserves, and diversified exposure limits across all business units.
Related Monetization Mechanics
Compare revenue streams, unit economics, and business models
Explore DexCom
Core profile pages, founders and related research hubs for this company.